Advertisement

Perfluorochemical Emulsions as Blood Substitutes

  • Robert J. Kaufman
Chapter
Part of the NATO ASI Series book series (ASIC, volume 363)

Abstract

Perfluorochemicals (PFC’s) dissolve large volumes of oxygen (35–52 vol. %) and carbon dioxide (135–160 vol. %) and are chemically and biochemically inert. These properties have made them candidates for blood substitutes and other therapeutic applications requiring oxygen delivery to tissues. In this paper, the history of PFC’s in medicine and the requirements for a successful commercial emulsion are briefly reviewed. The practical aspects and current status of the production of a safe, shelf stable, small particle size, high PFC content emulsion are reviewed and recent advances in the field such as new PFC’s, novel surfactants, new clinical trials and recent regulatory approvals are presented.

Keywords

Oxygen Transport Blood Substitute Liquid Ventilation Shock Resuscitation Perfluorocarbon Emulsion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Anonymous (1990) ‘Alpha Therapeutic’s Fluosol oxygen transport fluid approved for use in angioplasty; launch will be initiated at cardiologist conference in March’, FDC Reports 52, 8.Google Scholar
  2. Bajaj, A.K., Cobb, M.A., Virmani, R., et al. (1989) ‘Limitation of myocardial reperfusion injury by intravenous perfluorochemicals’, Circulation 79,645–656.CrossRefGoogle Scholar
  3. Blumberg, N., Agaral, M. and Chuang, C. (1985) ‘A possible association between survival time and transfusion in patients with cervical cancer’, Blood 66(suppl. 1), 274a.Google Scholar
  4. Burgan, A.R., Long, D.M., Mattrey, R.F., et al. (1987) ‘Results of pharmacokinetic and toxicologic studies with PFOB emulsions’, Biomaterials, Artificial Cells, and Artificial Organs 15, 367.Google Scholar
  5. Clark, L.C., and Gollan, F. (1966) ‘Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure’, Science 152, 1755–1756.CrossRefGoogle Scholar
  6. Clark, L.C., Wesseler, E., Miller, M. and Kaplan, S., (1974) ‘Ring versus straight chain perfluorocarbon emulsions for perfusion media’, Microvascular Research, 8, 320–340.CrossRefGoogle Scholar
  7. Cleman, M., Jaffe, C.C., and Wohlgelernter, D. (1986) ‘Prevention of ischemia during percutaneous transluminal coronary angioplasty by trans-catheter infusion of oxygenated Fluosol DA-20%’, Circulation 74, 555–562.CrossRefGoogle Scholar
  8. Elliott, L.A., Ledgerwood, A.M., Lucas, C.E., et al. (1989) ‘Role of Fluosol-DA 20% in prehospital resuscitation’, Critical Care Med. 17, 166–172.CrossRefGoogle Scholar
  9. Faithful, N.S., Erdmann, W., Fennema, M. and Kok, A. (1986) ‘Effects of haemodilution with fluorocarbons or dextran on oxygen tensions in the acutely ischemic myocardium’, Brit. J. Anesth. 58, 1031–1040.CrossRefGoogle Scholar
  10. Geyer, R.P., Monroe, R.C., and Taylor, K. (1968) ‘Survival of rats totally perfused with a fluorocarbon-detergent preparation’, in Organ Perfusion and Preservation (Norman, J., ed.), pp. 85–97, Appleton Century and Crofts, New York.Google Scholar
  11. Geyer, R.P., Taylor, K., Duffett, E., et al. (1973) ‘Successful complete replacement of the blood of living rats with artificial substitutes’, Fed. Proc. 32, 927.Google Scholar
  12. Gjaldbaek, J., and Hildebrand, J.H. (1949) ‘The solubility of nitrogen in carbon disulfide, benzene, normal and cyclo-hexane and in three fluorocarbons’, J. Am. Chem. Soc. 71, 3147.CrossRefGoogle Scholar
  13. Glogar, D.H., Kloner, R.A., Muller, J., et al. (1981) ‘Fluorocarbons reduce myocardial ischemic damage after coronary occlusion’, Science 211, 1439–1441.CrossRefGoogle Scholar
  14. Gould, S.A., Rosen, A.L., Sehgal, L.R., et al. (1986) ‘Transfusion trigger literature’, New England J. Med. 314, 1653–1656.CrossRefGoogle Scholar
  15. Haljamae, H., and Rosenberg, P.H. (1988) ‘Perioperative transfusion practice-An update’, Acta Anaesthesiol. Scand. 32(suppl. 89), 1–3.CrossRefGoogle Scholar
  16. Hamza, M.A., Serratrice, G., Stebe, M.-J., Delpuech, J.-J. (1981) ‘Solute-solvent interactions in perfluorocarbon solutions of oxygen. An NMR study’, J. Am. Chern. Soc. 103, 3733–3738.CrossRefGoogle Scholar
  17. Huestis, D.W., Bove, J.R., and Busch, S. (1981) Practical Blood Transfusion, Little Brown and Company, Boston.Google Scholar
  18. Jaffe, C.C., Wohlgelemter, D., and Cabin, H., et al. (1988) ‘Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated Fluosol DA 20%’, Am. Heart J. 6, 1156–1164.CrossRefGoogle Scholar
  19. Klubes, P.S., Hiraga, S., Richard, L.C., Owens, E.S. and Blasberg, R.G. (1987) ‘Attempts to increase intratumoral blood flow in the rat solid Walker 256 tumor by the use of perfluorocarbon emulsion Fluosol-DA’, Eur. J. Cancer Clin. 23,1859–1867.CrossRefGoogle Scholar
  20. Kolodgie, F.D., Dawson, A.K., Roden, D.M., et al. (1986) ‘Effect of Fluosol-DA on infarct morphology and vulnerability to ventricular arrhythmia”, Am. Heart J. 112, 1192–1201.CrossRefGoogle Scholar
  21. Liu, M.S., Rosen, A., and Long, D.M. (1973) ‘Biological disposition of perfluorooctylbromide-A new contrast agent’, Fed. Proc. 32, Abstr. No. 3982,927.Google Scholar
  22. Long, D.M., Multer, F.K., Greenburg, A.G., et al. (1978) ‘Tumor imaging with X-rays using macrophage uptake of radiopaque fluorocarbon emulsions’, Surgery 84, 104–112.Google Scholar
  23. Long, D.C., Fallano, R., Reiss, J.G., et al. (1987) ‘Preparation and applications of highly concentrated PFOB emulsions’, Biomaterials,_Artificial Cells, and Artificial Organs 15,417.Google Scholar
  24. Lowe, C.A., and Schaffer, T.H. (1986) ‘Pulmonary vascular resistance in the fluorocarbon-filled lung’, J. Appl. Physiol. 60, 154–159.Google Scholar
  25. Lowe, C., Tuma, R.F., Sevieri, E.M. and Schaffer, T.H. (1979) ‘Liquid ventilation: cardiovascular adjustments with secondary hyperlactatemia and acidosis.’, J. Appl. Physiol.:Respirat. Environ. Exercise Physiol. 47,1051–1057.Google Scholar
  26. Lustig, R.A., and McIntosh, N. (1986) ‘Fluosol-DA in radiation therapy’, Prog. Clin. and Biol. Res. 211, 29–38.Google Scholar
  27. Lustig, R., McIntosh-Lowe, N., Rose, C., et al. (1989a) ‘Phase I/II study of Fluosol-DA and 100% oxygen as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck.’, Int. J. Radiation Oncology Biol., and Phys. 16, 1587–1593.CrossRefGoogle Scholar
  28. Lustig R.A., Lowe, N., Prosnitz, L., et al. (1989b) ‘Phase I/II study of Fluosol and 100% oxygen breathing as an adjuvant to radiation in the treatment of unresectabel non small cell carcinoma of the lung’, Int. J. Radiation Oncology, Bio., and Phys 17,202.CrossRefGoogle Scholar
  29. Makowski, H. (1978) ‘The properties of Fluosol-DA infusion in the treatment of hemorrhagic shock’, in Proc. 4th International Symposium on Perfluorochemical Blood Substitutes, Oct 21-22, 1978, Kyoto Japan 439–448, Excerpta Medica, Amsterdam.Google Scholar
  30. Mattrey, R.F., Hilpert, P.L., Long, C.D. et al. (1989) ‘Hemodynamic effects of intravenous lecithin-based perfluorocarbon emulsions in dogs’, Critical Care Medicine 17, 652–656.CrossRefGoogle Scholar
  31. Mitsuno, T., Ohyanagi, H., and Naito, R. (1982) ‘Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA): Summary of 186 cases’, Ann. Surg. 195,60–69.CrossRefGoogle Scholar
  32. Mitsuno, T., and Ohyanagi, H. (1985) “Present status of clinical studies of Fluosol-DA (20%) in Japan in Tremper, K. (ed), International Anesthisiology Clinics. Perfluorochemical Oxygen Transport, Little, Brown and Company Publishers, Boston pp. 169–184.Google Scholar
  33. Modell, J.H., Gollan, F., Giammona, S.T. and Parker, D. (1970a) ‘Effect of fluorocarbon liquid on surface tension properties of pulmonary surfactant’, Chest 57, 263–265CrossRefGoogle Scholar
  34. Modell, J.H., Newby, E.J. and Ruiz, B.C. (1970b) ‘Long-term survival of dogs after breathing oxygenated fluorocarbon liquid’, Fed. Proc. 29, 1731–1736.Google Scholar
  35. Modell, J.H., Hood, C.I., Kuck, E.J. and Ruiz, B.C. (1971) ‘Oxygenation by ventilation with fluorocarbon liquid (FX-80)’, Fed. Proc. 34, 312–320.Google Scholar
  36. Modell, J.H., Calderwood, H.W., Ruiz, B.C., Tham, M.K., and Hood, C.I. (1976) ‘Liquid ventilation of primates’, Chest 69, 79–81.CrossRefGoogle Scholar
  37. Moore, R.E., and Clark, L.C. (1985) ‘Chemistry of fluorocarbons in biomedical use’, in Tremper, K. (ed), International Anesthisiology Clinics. Perfluorochemical Oxygen Transport, Little Brown and Company Publishers, Boston pp. 11–24.Google Scholar
  38. Nunn, G.R., Dance, G., Peters, J., and Cohn, L.H. (1983) ‘Effect of fluorocarbon exchange transfusion on myocardial infarction size in dogs’, Am. J. Cardiol. 52, 203–205.CrossRefGoogle Scholar
  39. Ohyanagi, H., and Mitsuno, T. (1975) ‘Biophysiological effects of perfluorochemicals as artificial blood’, in Proc. of the Post Congress Symposium, Xth International Congress of Nutrition on Perfluorochemical Blood, Kyoto, Japan, pp.21–54.Google Scholar
  40. Ohyanagi, H., Sekita, M., Yokoyama, K., et al. (1978) ‘Studies on perfluorochemical emulsion (Fluosol DA) as artificial blood in exchange transfusion and emergency use in monkeys’, in Proc. of the 4th International Symposium on Perfluorochemical Blood Substitutes, Oct. 21-22, 1978, Kyoto Japan, pp.373–389. Excerpta Medica, AmsterdamGoogle Scholar
  41. Ohyanagi, H., Nishijima, M., Usami, M., et al. (1983) ‘Experimental studies on the possible combined chemotherapy to neoplasms with Fluosol-DA infusion’, Prog. Clin. Biol. Res. 211, 315–320.Google Scholar
  42. Ohyanagi, H., Nakaya, S., Okumura, S., and Saitoh, Y. (1984) ‘Surgical use of Fluosol-DA in Jehovah’s Witness patients’, Artificial Organs 8, 110–118.Google Scholar
  43. Okada, K., Kosugi, I., Kawashima, Y. et al. (1975) ‘Effect of Fluosol-DC on tissue pO2 and pCO2 in treatment of hemorrhagic hypotension’, in Proc. of the Post Congress Symposium, Xth International Congress of Nutrition on Perfluorochemical Blood, Kyoto, Japan, pp.215–224.Google Scholar
  44. Reiss, J.G. and LeBlanc, M. (1978) ‘Perfluoro compounds as blood substitutes’ Angew. Chem. Int. Ed. Engl., 17,621–634.CrossRefGoogle Scholar
  45. Reiss, J.G. (1984) ‘Reassessment of Criteria for the selection of perfluorochemicals for second-generation blood substitutes: A analysis of structure/property relationships’, Artif. Organs, 8,44–56.CrossRefGoogle Scholar
  46. Rockwell, S. (1985) ‘Use of perfluorochemical emulsion to improve oxygenation in a solid tumor’, Int J. Radiation Oncology, Biol. and Phys. 11, pp.97–103.CrossRefGoogle Scholar
  47. Rockwell, S. (1988) Personal Communication, Yale Medical Center, Hunter Radiation Center, New Haven, CT.Google Scholar
  48. Rose, C.M., Lustig, R., McIntosh, N., and Teicher, B. (1986) ‘A clinical trial of Fluosol DA 20% in advanced squamous cell carcinoma of the head and neck’, Int. J. Radiation Oncology, Biol. and Phys. 12, 1325–1327.CrossRefGoogle Scholar
  49. Rosen, A.L., Sehgal, L.R., Gould, S.S., Sehgal, H.L., Moss, G.S. (1985) ‘Transport of oxygen by perfluorochemical emulsions’, in Tremper, K. (ed), International Anesthisiology Clinics. Perfluorochemical Oxygen Transport, Little Brown and Company Publishers, Boston pp. 95–103.Google Scholar
  50. Rosenblum, W.I., Moncure, C.W. and Behm, F.G. (1985) ‘Some long-term effects of exchange transfusion with fluorocarbon emulsions in macaque monkeys’, Arch. Pathol. Lab Med. 109, 340–344.Google Scholar
  51. Rufer, R., and Spitzer, H.L. (1974) ‘Liquid ventilation in the respiratory distress syndrome’, Chest 66(suppl.) 29S–30S.CrossRefGoogle Scholar
  52. Schaffer, T.H., and Moskowitz, G.D. (1974) ‘Demand-controlled liquid ventilation of the lungs’, J. Applied Physiology 36, 208–213.Google Scholar
  53. Schaffer, T.H., Rubenstein, D., Moskowitz, G.D. and Delivoria-Papadopoulos, M. (1976) ‘Gaseous exchange and acid-base balance in premature lambs during liquid ventilation since birth’, Pediat. Res. 10,227–231.CrossRefGoogle Scholar
  54. Schaffer, T.H., Tran, N., Bhutani, V.K., and Sivieri, E.M. (1983) ‘Cardiopulmonary function in very preterm lambs during liquid ventilation’, Pediat Res. 17, 680–684.CrossRefGoogle Scholar
  55. Shaw, R.F. and Clark, L.C. (1987) “Stable emulsions of highly fluorinated organic compounds’ European patent application no. 0 231 091.Google Scholar
  56. Sloviter, H., and Kamimoto, T. (1967) ‘Erythrocyte substitute for perfusion of brain’, Nature 216,458.CrossRefGoogle Scholar
  57. Song, C.W., Zhang, W.L., Pence, D.M., et al. (1986) ‘Increased radiosensitivity of tumors by perfluorochemicals and carbogen’, Int. J. Radiation Oncology, Biol. and Phys. 12,934–936.Google Scholar
  58. Song, C.W., Lee, I., Hasegawa, T., et al. (1987) ‘Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen’, Cancer Res. 47, 442–446.Google Scholar
  59. Spears, J.R., Serur, J., Baim, D.S. et al. (1983) ‘Myocardial protection with Fluosol-DA during prolonged coronary balloon occlusion in the dog’, Circulation 68(suppl. III), 317.Google Scholar
  60. Spence, R.K., McCoy, S., Costabile, J., et al. (1989) ‘Fluosol DA-20% in treatment of severe anemia: A randomized, controlled study of 47 patients’, Critical Care Med. 17, S144.CrossRefGoogle Scholar
  61. Suyama, T., Matsumoto, T., Watanabe, M., Hamano, T., and Naito, R. (1975) ‘Exchange transfusion with perfluorodecalin emulsion (Fluosol-DC) in severely hemodiluted dogs’, in Proc. of the Post Congress Symposium, Xth International Congress of Nutrition on Perfluorochemical Blood, Kyoto, Japan, pp. 225–235.Google Scholar
  62. Teicher, B.A., and Holden, S.A. (1987) ‘Survey of the effect of adding Fluosol-DA 20% O2 to treatment with various chemotherapeutic agents’, Cancer Treatment Reports 71Google Scholar
  63. Teicher, B., and Rockwell, S. (1983) ‘Increased efficacy of radiotherapy in mice treated with perfluorochemical emulsions plus oxygen’, Amer. Assoc. of Cancer Res. Abst. 25–28, May 1983.Google Scholar
  64. Teicher, B.A., and Rose, C.M. (1984) ‘Perfluorochemical emulsions can increase tumor radiosensitivity’, Science 223, 934–936.CrossRefGoogle Scholar
  65. Thomlinson, R.H., and Gray, L.H. (1955) ‘The histological structure of some human lung cancers and the possible implications for radiotherapy’, Brit. J. Cancer 9, 539–549.CrossRefGoogle Scholar
  66. Tremper, K.K., Levine, E.M. and Waxman, K. (1985) ‘Clinical Experience with Fluosol-DA (20%) in the United States’, in Perfluorochemical Oxygen Transport (Tremper, K, ed.), Little Brown and Company, Boston, pp 185–197.Google Scholar
  67. Tsuda, Y. and Yokoyama, K. (1989) ‘Perfluorochemical emulsions: The industrial view’, Abstract no. 698 International Chemical Congress of Pacific Basin, Dec. 17-22, 1989, Honolulu, Hawaii.Google Scholar
  68. Waldrop, M.M. (1989) ‘The (liquid) breath of life’, Science 245, 1043–1045.CrossRefGoogle Scholar
  69. Yokoyama, K., Yamanouchi, K., and Watanahi, M., et al. (1975) ‘Preparation of perfluorodecalin emulsion, an approach to the red cells substitute’, Fed. Proc. 34, 1478–1483.Google Scholar
  70. Yokoyama, K., Suyama, T. and Naito, R. (1982) ‘Selection of 53 PFC substances for better stability’, Proc. Int. Sym., San Francisco, Ca. Sept. 29-0ct. 1, pp 189–196.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1992

Authors and Affiliations

  • Robert J. Kaufman
    • 1
  1. 1.HemaGen/PFCSt. LouisUSA

Personalised recommendations